|
|
||||||||
|
|
|||||||||
|
|
Radiopharmaceutical Chemistry: New Chemistry-OtherNew Chemistry-Other Posters |
1 Psychiatry and Radiology; 2 Radiology; 3 Medicine; 4 Surgery, Columbia University Medical Center, New York, New York
1275
Objectives: In the treatment of diabetes, islet transplantation (iTx) to the liver reestablishes normal feedback regulation of insulin secretion and normoglycemia. The Edmonton iTx protocol is associated with good short-term success but only a 10-15% success rate by 5 years post-iTx. Understanding islet graft failure and a non invasive method to estimate transplanted β-cell mass seems prerequisite before iTx outcomes improve. β-cell mass (BCM) measurements by PET with [11C] DTBZ is not suitable for islets transplanted to the liver due to catabolism of the radioligand. Here we show feasibility of estimating BCM in iTx to an extrahepatic site- the intramuscular space of the abdominal wall prevascualrized with alginate scaffold containing RGD peptide and vascular growth factors.
Methods: Normal Lewis rats were made diabetic with streptozotocin and then transplanted with 3000 purified allogeneic ACI islets. ITx reversed diabetes by day 2 and the abdomen was imaged (90 min) dynamically using 250 +/-50 µCi [11C]DTBZ and a Concorde microPET scanner on day six post Tx.
Results: In transplanted rodents without reversal of hyperglycemia and sham operated rodents, no preperitoneal uptake of radioligand was demonstrated. In diabetic rodents with euglycemia restored by iTx, an intramuscular islet cell mass is clearly revealed by uptake of [11C]DTBZ.
Conclusions: For islets transplanted to non hepatic sites, PET scans with [11C]DTBZ may offer a means to monitor islet graft function and survival.
| ||||||||||||||||||||||||||||||||||||||